000 01517 a2200469 4500
005 20250516025711.0
264 0 _c20110725
008 201107s 0 0 eng d
022 _a1651-2057
024 7 _a10.2340/00015555-1025
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDelage, Maïa
245 0 0 _aEfficacy of infliximab for hidradenitis suppurativa: assessment of clinical and biological inflammatory markers.
_h[electronic resource]
260 _bActa dermato-venereologica
_cMar 2011
300 _a169-71 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAnti-Inflammatory Agents
_xadverse effects
650 0 4 _aAntibodies, Monoclonal
_xadverse effects
650 0 4 _aC-Reactive Protein
_xmetabolism
650 0 4 _aDrug Eruptions
650 0 4 _aFemale
650 0 4 _aHidradenitis Suppurativa
_xblood
650 0 4 _aHumans
650 0 4 _aInfliximab
650 0 4 _aLeukocyte Count
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeutrophils
_xmetabolism
650 0 4 _aPain
650 0 4 _aQuality of Life
650 0 4 _aRetrospective Studies
650 0 4 _aTreatment Outcome
650 0 4 _aYoung Adult
700 1 _aSamimi, Mahtab
700 1 _aAtlan, Michaël
700 1 _aMachet, Laurent
700 1 _aLorette, Gerárd
700 1 _aMaruani, Annabel
773 0 _tActa dermato-venereologica
_gvol. 91
_gno. 2
_gp. 169-71
856 4 0 _uhttps://doi.org/10.2340/00015555-1025
_zAvailable from publisher's website
999 _c20656595
_d20656595